Raleigh Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,453
Closed -$2.47K 1062
2023
Q4
$2.47K Buy
+1,453
New +$2.47K ﹤0.01% 845